SUBSCRIBE
SUBSCRIBE

Bispecific

Handshake of man and robot. Modern technologies. Art collage.
Artificial intelligence
Genentech makes $1.5B+ deal with AI heavyweight Earendil for cancer bispecifics
Genentech’s agreement with Earendil Labs came the same day its parent company, Roche, inked a cardiometabolic and renal deal with Atavistik Bio for up to $2 billion.
September 25, 2026
 · 
2 min read
 · 
Tristan Manalac
Investment mistakes, taxes, expenses, and unknown costs drain money, concept of Businessman carries a money bag with a big hole, banknotes falling out
Immunology and inflammation
Roche bets up to $1B to advance next-gen bispecifics with Dualitas
The partners will focus R&D efforts on immunological and inflammatory conditions using Dualitas’ DualScreen Bispecific Discovery Engine platform.
September 17, 2026
 · 
1 min read
 · 
Tristan Manalac
An architect designs a building on a laptop. Art collage.
Insights
Multispecifics are transforming the CDMO development architecture
Manufacturers are being pushed beyond mAb‑era platforms into a new design model built around molecular engineering, complex analytics and amplified upstream and downstream processing.
August 28, 2026
 · 
6 min read
 · 
Jennifer C. Smith-Parker
PRESS RELEASES
Press Releases
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Granted FDA Fast Track Designation for First-Line Advanced or Metastatic Biliary Tract Cancer
October 12, 2026
 · 
8 min read
Press Releases
InnoCare Announces Approval of Clinical Trial of Bispecific Antibody ICP-B161 Targeting TL1A and IL-23p19 in China
October 12, 2026
 · 
2 min read
Press Releases
HCW Biologics Maintains Momentum Toward Completion of IND Application for Clinical Study to Evaluate Lead T-Cell Engager in Solid Tumors
October 12, 2026
 · 
5 min read
Press Releases
NovaBridge Biosciences Announces Expanded Givastomig Safety and Efficacy Data to be Presented at the European Society for Medical Oncology 2026
October 8, 2026
 · 
6 min read
Press Releases
AbbVie and Genmab Announce Epcoritamab in Combination with R-CHOP Demonstrates Significant Improvement in Progression-Free Survival versus R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
October 5, 2026
 · 
19 min read
Press Releases
Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
October 5, 2026
 · 
13 min read
Press Releases
Catalent Launches Accelerated Gene-to-Drug Substance Program for Complex Molecules in the U.S.
October 5, 2026
 · 
2 min read
Press Releases
AstraZeneca Completes $2 Billion Equity Investment in Summit Therapeutics
October 5, 2026
 · 
12 min read
Press Releases
Bambusa Therapeutics Initiates Subcutaneous Dosing of BBT001 in Atopic Dermatitis, Following Compelling Intravenous Proof-of-Concept Data
October 1, 2026
 · 
5 min read
Press Releases
Phrontline Biopharma Doses First Patient in Global Phase I/II Trial of TJ102, an FRα × CDH6 Bispecific Dual-Payload ADC
September 30, 2026
 · 
3 min read
Press Releases
Navigator Medicines Presents New Data at EADV 2026 as Bispecific Antibody Program Advances at Speed in Hidradenitis Suppurativa
September 30, 2026
 · 
6 min read
Press Releases
Aethlon Medical & North Immunology Announce Merger to Advance Novel IL-13 x IL-18 Bispecific Antibody for Atopic Dermatitis
September 17, 2026
 · 
15 min read